Cibus Q1 net loss narrows to $21.2M; Rice HT U.S. launch pushed to 2029

Cibus, Inc.

2026-Q1 EPS reported -$0.33 revenue$1,681,000

Net loss of $21.2M ($0.33/share) vs $49.4M ($1.34) in Q1 2025; no goodwill impairment this quarter.
Cash at $30.3M; net cash usage guidance of ~$30M or less in 2026.
Rice HT program: U.S. launch rescheduled to 2029 due to herbicide registration delay; LATAM launch still targeted for 2027.
Q1 revenue increased YoY; R&D down 26% to $8.7M, SG&A down 48% to $5.1M on cost cuts.
Raised ~$37.3M in two equity offerings YTD 2026; Thomas Urban appointed to Board.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Cibus, Inc. reported financial results for the quarter ended March 31, 2026.

Period: the quarter ended March 31, 2026
Result: reported results

Exact text from the filing

On May 14, 2026, Cibus, Inc. (the “Company”) announced its financial results for the three months ended March 31, 2026, and provided a business update.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Cibus, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-035105

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.